{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:26:57Z","timestamp":1787617617279,"version":"build-2736575974"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["220007"],"award-info":[{"award-number":["220007"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["196862"],"award-info":[{"award-number":["196862"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Peptides and proteins containing defined\n                    <jats:italic>N<\/jats:italic>\n                    -glycans hold great promise for biomedicine because the attached glycans engage in specific interactions, influence targeted delivery and folding, and improve pharmacokinetic properties. However, challenges associated with producing homogeneous\n                    <jats:italic>N<\/jats:italic>\n                    -glycoconjugates hinder their wider application. Here, we report the development of GLYCO-BUILD, an enzymatic pipeline that can generate glycopeptides carrying eukaryotic\n                    <jats:italic>N<\/jats:italic>\n                    -glycans at a level of homogeneity not accessible by alternative methodologies. The pipeline recapitulates the endoplasmic reticulum-based steps of the eukaryotic protein\n                    <jats:italic>N<\/jats:italic>\n                    -glycosylation machinery. However, it employs a combination of enzymes of archaeal, bacterial, and eukaryotic origin that are able to process inexpensive phytol instead of the native dolichol as a lipid carrier. GLYCO-BUILD facilitates the synthesis of homogeneous\n                    <jats:italic>N<\/jats:italic>\n                    -glycans ranging from GlcNAc\n                    <jats:sub>2<\/jats:sub>\n                    to GlcNAc\n                    <jats:sub>2<\/jats:sub>\n                    Man\n                    <jats:sub>9<\/jats:sub>\n                    Glc\n                    <jats:sub>3<\/jats:sub>\n                    , and their transfer to acceptor polypeptides using single-subunit oligosaccharyltransferases (OSTs) from the eukaryotic parasite\n                    <jats:italic>Trypanosoma brucei<\/jats:italic>\n                    . We used GLYCO-BUILD to generate glycopeptides mimicking viral mannosylated antigens, glucosylated species and precursors of complex and hybrid glycans. Our pipeline is modular, versatile and can be combined with other approaches of glycan extension and modification to generate a wide range of homogeneous\n                    <jats:italic>N<\/jats:italic>\n                    -glycoconjugates for use in research, diagnostics and therapeutics, including serum testing, vaccine development or modulation of biotherapeutics\u2019 half-life.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-67055-2","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T15:16:17Z","timestamp":1764429377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["GLYCO-BUILD: an enzymatic pipeline for the synthesis of peptides carrying eukaryotic N-glycans"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-3260","authenticated-orcid":false,"given":"Lorenzo","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8759-1389","authenticated-orcid":false,"given":"J. Andrew N.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1619-0721","authenticated-orcid":false,"given":"Ana S.","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8207-2889","authenticated-orcid":false,"given":"Kaspar P.","family":"Locher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"67055_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0304-4165(99)00165-8","volume":"1473","author":"R Apweiler","year":"1999","unstructured":"Apweiler, R., Hermjakob, H. & Sharon, N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1473, 4\u20138 (1999).","journal-title":"Biochim. Biophys. Acta"},{"key":"67055_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/glycob\/cww086","volume":"27","author":"A Varki","year":"2017","unstructured":"Varki, A. Biological roles of glycans. Glycobiology 27, 3\u201349 (2017).","journal-title":"Glycobiology"},{"key":"67055_CR3","unstructured":"Varki, A. et al. Essentials of Glycobiology, 4th edn, (Cold Spring Harbor Press, 2022)."},{"key":"67055_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2165\/11530550-000000000-00000","volume":"24","author":"RJ Sola","year":"2010","unstructured":"Sola, R. J. & Griebenow, K. Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs 24, 9\u201321 (2010).","journal-title":"BioDrugs"},{"key":"67055_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-chembioeng-102419-010001","volume":"11","author":"NI Majewska","year":"2020","unstructured":"Majewska, N. I., Tejada, M. L., Betenbaugh, M. J. & Agarwal, N. N-Glycosylation of IgG and IgG-like recombinant therapeutic proteins: why is it important and how can we control it? Annu. Rev. Chem. Biomol. Eng. 11, 311\u2013338 (2020).","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"67055_CR6","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1039\/C5SC04392A","volume":"7","author":"SV Moradi","year":"2016","unstructured":"Moradi, S. V., Hussein, W. M., Varamini, P., Simerska, P. & Toth, I. Glycosylation, an effective synthetic strategy to improve the bioavailability of therapeutic peptides. Chem. Sci. 7, 2492\u20132500 (2016).","journal-title":"Chem. Sci."},{"key":"67055_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tetasy.2004.11.038","volume":"16","author":"RD Egleton","year":"2005","unstructured":"Egleton, R. D. et al. Biousian glycopeptides penetrate the blood-brain barrier. Tetrahedron Asymmetry 16, 65\u201375 (2005).","journal-title":"Tetrahedron Asymmetry"},{"key":"67055_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202300111","volume":"29","author":"H Ochiai","year":"2023","unstructured":"Ochiai, H. et al. Better peptides via chemical glycosylation: somatostatin analogues having a human complex-type N-glycan with improved drug properties. Chemistry 29, e202300111 (2023).","journal-title":"Chemistry"},{"key":"67055_CR9","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3389\/fmicb.2017.01415","volume":"8","author":"SSL Yap","year":"2017","unstructured":"Yap, S. S. L., Nguyen-Khuong, T., Rudd, P. M. & Alonso, S. Dengue virus glycosylation: what do we know? Front. Microbiol. 8, 1415 (2017).","journal-title":"Front. Microbiol."},{"key":"67055_CR10","doi-asserted-by":"publisher","first-page":"D339","DOI":"10.1093\/nar\/gky1006","volume":"47","author":"R Vita","year":"2019","unstructured":"Vita, R. et al. The Immune Epitope Database (IEDB): 2018 update. Nucleic Acids Res. 47, D339\u2013D343 (2019).","journal-title":"Nucleic Acids Res."},{"key":"67055_CR11","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.jmb.2013.02.025","volume":"425","author":"H Pantua","year":"2013","unstructured":"Pantua, H. et al. Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies. J. Mol. Biol. 425, 1899\u20131914 (2013).","journal-title":"J. Mol. Biol."},{"key":"67055_CR12","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.1213256","volume":"334","author":"R Pejchal","year":"2011","unstructured":"Pejchal, R. et al. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 334, 1097\u20131103 (2011).","journal-title":"Science"},{"key":"67055_CR13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature10373","volume":"477","author":"LM Walker","year":"2011","unstructured":"Walker, L. M. et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477, 466\u2013470 (2011).","journal-title":"Nature"},{"key":"67055_CR14","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.chembiol.2017.09.005","volume":"24","author":"H Cai","year":"2017","unstructured":"Cai, H. et al. Synthetic three-component HIV-1 V3 glycopeptide immunogens induce glycan-dependent antibody responses. Cell Chem. Biol. 24, 1513\u20131522.e1514 (2017).","journal-title":"Cell Chem. Biol."},{"key":"67055_CR15","doi-asserted-by":"publisher","unstructured":"Alam, S. M. et al. Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide. Sci. Transl. Med. 9 https:\/\/doi.org\/10.1126\/scitranslmed.aai7521 (2017).","DOI":"10.1126\/scitranslmed.aai7521"},{"key":"67055_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16319-0","volume":"11","author":"L Sun","year":"2020","unstructured":"Sun, L. et al. Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help. Nat. Commun. 11, 2550 (2020).","journal-title":"Nat. Commun."},{"key":"67055_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/glycob\/cwn099","volume":"19","author":"S Thobhani","year":"2009","unstructured":"Thobhani, S., Yuen, C. T., Bailey, M. J. & Jones, C. Identification and quantification of N-linked oligosaccharides released from glycoproteins: an inter-laboratory study. Glycobiology 19, 201\u2013211 (2009).","journal-title":"Glycobiology"},{"key":"67055_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2024.103145","volume":"87","author":"MR Kao","year":"2024","unstructured":"Kao, M. R., Karmarkar Saldivar, R. & Hsieh, Y. S. Y. Production of therapeutic glycoproteins in glycoengineered plant: old farm for new crops. Curr. Opin. Biotechnol. 87, 103145 (2024).","journal-title":"Curr. Opin. Biotechnol."},{"key":"67055_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2025.100981","volume":"24","author":"S Yan","year":"2025","unstructured":"Yan, S. et al. Glycoproteomic and single-protein glycomic analyses reveal zwitterionic N-glycans on natural and recombinant proteins derived from insect cells. Mol. Cell Proteom. 24, 100981 (2025).","journal-title":"Mol. Cell Proteom."},{"key":"67055_CR20","doi-asserted-by":"publisher","unstructured":"Oh, M. J., Seo, Y., Seo, N. & An, H. J. MS-based glycome characterization of biotherapeutics with N- and O-glycosylation. Mass Spectrom. Rev. https:\/\/doi.org\/10.1002\/mas.21925 (2025).","DOI":"10.1002\/mas.21925"},{"key":"67055_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47693-8","volume":"15","author":"LF Schachner","year":"2024","unstructured":"Schachner, L. F. et al. Exposing the molecular heterogeneity of glycosylated biotherapeutics. Nat. Commun. 15, 3259 (2024).","journal-title":"Nat. Commun."},{"key":"67055_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05110-x","volume":"9","author":"T Jaroentomeechai","year":"2018","unstructured":"Jaroentomeechai, T. et al. Single-pot glycoprotein biosynthesis using a cell-free transcription-translation system enriched with glycosylation machinery. Nat. Commun. 9, 2686 (2018).","journal-title":"Nat. Commun."},{"key":"67055_CR23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nchembio.921","volume":"8","author":"JD Valderrama-Rincon","year":"2012","unstructured":"Valderrama-Rincon, J. D. et al. An engineered eukaryotic protein glycosylation pathway in Escherichia coli. Nat. Chem. Biol. 8, 434\u2013436 (2012).","journal-title":"Nat. Chem. Biol."},{"key":"67055_CR24","doi-asserted-by":"publisher","first-page":"8849","DOI":"10.1074\/jbc.M112.445940","volume":"288","author":"S Gerber","year":"2013","unstructured":"Gerber, S. et al. Mechanism of bacterial oligosaccharyltransferase: in vitro quantification of sequon binding and catalysis. J. Biol. Chem. 288, 8849\u20138861 (2013).","journal-title":"J. Biol. Chem."},{"key":"67055_CR25","doi-asserted-by":"publisher","first-page":"15603","DOI":"10.1021\/acs.chemrev.1c01032","volume":"122","author":"SS Shivatare","year":"2022","unstructured":"Shivatare, S. S., Shivatare, V. S. & Wong, C. H. Glycoconjugates: synthesis, functional studies, and therapeutic developments. Chem. Rev. 122, 15603\u201315671 (2022).","journal-title":"Chem. Rev."},{"key":"67055_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1021\/acscentsci.8b00588","volume":"5","author":"DN Nguyen","year":"2019","unstructured":"Nguyen, D. N. et al. Oligomannose glycopeptide conjugates elicit antibodies targeting the glycan core rather than its extremities. ACS Cent. Sci. 5, 237\u2013249 (2019).","journal-title":"ACS Cent. Sci."},{"key":"67055_CR27","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.carres.2008.03.025","volume":"343","author":"LX Wang","year":"2008","unstructured":"Wang, L. X. Chemoenzymatic synthesis of glycopeptides and glycoproteins through endoglycosidase-catalyzed transglycosylation. Carbohydr. Res. 343, 1509\u20131522 (2008).","journal-title":"Carbohydr. Res."},{"key":"67055_CR28","doi-asserted-by":"publisher","unstructured":"Wei, F. Y., Zang, L. L., Zhang, P. F., Zhang, J. B. & Wen, L. Q. Concise chemoenzymatic synthesis of N-glycans. Chem 10 https:\/\/doi.org\/10.1016\/j.chempr.2024.05.006 (2024).","DOI":"10.1016\/j.chempr.2024.05.006"},{"key":"67055_CR29","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/glycob\/cwx017","volume":"27","author":"AS Ramirez","year":"2017","unstructured":"Ramirez, A. S. et al. Characterization of the single-subunit oligosaccharyltransferase STT3A from Trypanosoma brucei using synthetic peptides and lipid-linked oligosaccharide analogs. Glycobiology 27, 525\u2013535 (2017).","journal-title":"Glycobiology"},{"key":"67055_CR30","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/glycob\/cwx045","volume":"27","author":"AS Ram\u00edrez","year":"2017","unstructured":"Ram\u00edrez, A. S. et al. Chemo-enzymatic synthesis of lipid-linked GlcNAc2Man5 oligosaccharides using recombinant Alg1, Alg2 and Alg11 proteins. Glycobiology 27, 726\u2013733 (2017).","journal-title":"Glycobiology"},{"key":"67055_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09752-3","volume":"10","author":"ST Li","year":"2019","unstructured":"Li, S. T. et al. Reconstitution of the lipid-linked oligosaccharide pathway for assembly of high-mannose N-glycans. Nat. Commun. 10, 1813 (2019).","journal-title":"Nat. Commun."},{"key":"67055_CR32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41586-020-2044-z","volume":"579","author":"JS Bloch","year":"2020","unstructured":"Bloch, J. S. et al. Structure and mechanism of the ER-based glucosyltransferase ALG6. Nature 579, 443\u2013447 (2020).","journal-title":"Nature"},{"key":"67055_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jbiotec.2020.07.003","volume":"322","author":"TFT Rexer","year":"2020","unstructured":"Rexer, T. F. T. et al. Synthesis of lipid-linked oligosaccharides by a compartmentalized multi-enzyme cascade for the in vitro N-glycosylation of peptides. J. Biotechnol. 322, 54\u201365 (2020).","journal-title":"J. Biotechnol."},{"key":"67055_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-35067-x","volume":"13","author":"AS Ram\u00edrez","year":"2022","unstructured":"Ram\u00edrez, A. S. et al. Molecular basis for glycan recognition and reaction priming of eukaryotic oligosaccharyltransferase. Nat. Commun. 13, 1\u201312 (2022).","journal-title":"Nat. Commun."},{"key":"67055_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1266431","volume":"10","author":"L Wenzel","year":"2023","unstructured":"Wenzel, L., Hoffmann, M., Rapp, E., Rexer, T. F. T. & Reichl, U. Cell-free N-glycosylation of peptides using synthetic lipid-linked hybrid and complex N-glycans. Front. Mol. Biosci. 10, 1266431 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"67055_CR36","doi-asserted-by":"publisher","unstructured":"de Capitani, M. M. et al. Synthesis and characterisation of fluorescent substrates for eukaryotic protein N-glycosylation. Tetrahedron, 133361 https:\/\/doi.org\/10.1016\/j.tet.2023.133361 (2023).","DOI":"10.1016\/j.tet.2023.133361"},{"key":"67055_CR37","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1055\/s-0037-1609735","volume":"50","author":"JM Boilevin","year":"2018","unstructured":"Boilevin, J. M. & Reymond, J. L. Synthesis of lipid-linked oligosaccharides (LLOs) and their phosphonate analogues as probes to study protein glycosylation enzymes. Synthesis 50, 2631\u20132654 (2018).","journal-title":"Synthesis"},{"key":"67055_CR38","doi-asserted-by":"crossref","unstructured":"Meirelles, M. A. & Reymond, J.-L. Optimizing phosphate couplings for dolichyl diphosphochitobiose to enable protein N-Glycosylation studies. Helv. Chim. Acta 106, e202300171 (2023).","DOI":"10.1002\/hlca.202300171"},{"key":"67055_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Therapeutic peptides: current applications and future directions. Signal Transduct. Target Ther. 7, 48 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"67055_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2023.108206","volume":"67","author":"F Rocamora","year":"2023","unstructured":"Rocamora, F. et al. Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies. Biotechnol. Adv. 67, 108206 (2023).","journal-title":"Biotechnol. Adv."},{"key":"67055_CR41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/glycob\/2.4.313","volume":"2","author":"KR McLachlan","year":"1992","unstructured":"McLachlan, K. R. & Krag, S. S. Substrate specificity of N-acetylglucosamine 1-phosphate transferase activity in Chinese hamster ovary cells. Glycobiology 2, 313\u2013319 (1992).","journal-title":"Glycobiology"},{"key":"67055_CR42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1432-1033.1980.tb04527.x","volume":"105","author":"G Palamarczyk","year":"1980","unstructured":"Palamarczyk, G., Lehle, L., Mankowski, T., Chojnacki, T. & Tanner, W. Specificity of solubilized yeast glycosyl transferases for polyprenyl derivatives. Eur. J. Biochem. 105, 517\u2013523 (1980).","journal-title":"Eur. J. Biochem."},{"key":"67055_CR43","doi-asserted-by":"publisher","first-page":"8060","DOI":"10.1002\/anie.201402313","volume":"53","author":"LY Huang","year":"2014","unstructured":"Huang, L. Y. et al. Enzymatic synthesis of lipid II and analogues. Angew. Chem. Int. Ed. 53, 8060\u20138065 (2014).","journal-title":"Angew. Chem. Int. Ed."},{"key":"67055_CR44","doi-asserted-by":"publisher","first-page":"11042","DOI":"10.1074\/jbc.M115.713156","volume":"291","author":"Y Taguchi","year":"2016","unstructured":"Taguchi, Y., Fujinami, D. & Kohda, D. Comparative analysis of archaeal lipid-linked oligosaccharides that serve as oligosaccharide donors for Asn glycosylation. J. Biol. Chem. 291, 11042\u201311054 (2016).","journal-title":"J. Biol. Chem."},{"key":"67055_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00792-016-0890-2","volume":"21","author":"BH Meyer","year":"2017","unstructured":"Meyer, B. H., Shams-Eldin, H. & Albers, S. V. AglH, a thermophilic UDP-N-acetylglucosamine-1-phosphate:dolichyl phosphate GlcNAc-1-phosphotransferase initiating protein N-glycosylation pathway in Sulfolobus acidocaldarius, is capable of complementing the eukaryal Alg7. Extremophiles 21, 121\u2013134 (2017).","journal-title":"Extremophiles"},{"key":"67055_CR46","doi-asserted-by":"crossref","unstructured":"Meyer, B. H. et al. Agl24 is an ancient archaeal homolog of the eukaryotic N-glycan chitobiose synthesis enzymes. Elife 11, e67448 (2022).","DOI":"10.7554\/eLife.67448"},{"key":"67055_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1008078","volume":"10","author":"CD Wang","year":"2022","unstructured":"Wang, C. D. et al. An in vitro assay for enzymatic studies on human ALG13\/14 heterodimeric UDP-N-acetylglucosamine transferase. Front. Cell Dev. Biol. 10, 1008078 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"67055_CR48","doi-asserted-by":"crossref","unstructured":"Ramirez, A. S. & Locher, K. P. Structural and mechanistic studies of the N-glycosylation machinery: from lipid-linked oligosaccharide biosynthesis to glycan transfer. Glycobiology 33, 861\u2013872 (2023).","DOI":"10.1093\/glycob\/cwad053"},{"key":"67055_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00187-2","volume":"8","author":"R Gandini","year":"2017","unstructured":"Gandini, R., Reichenbach, T., Tan, T. C. & Divne, C. Structural basis for dolichylphosphate mannose biosynthesis. Nat. Commun. 8, 120 (2017).","journal-title":"Nat. Commun."},{"key":"67055_CR50","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/glycob\/cws003","volume":"22","author":"L Izquierdo","year":"2012","unstructured":"Izquierdo, L., Mehlert, A. & Ferguson, M. A. The lipid-linked oligosaccharide donor specificities of Trypanosoma brucei oligosaccharyltransferases. Glycobiology 22, 696\u2013703 (2012).","journal-title":"Glycobiology"},{"key":"67055_CR51","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1038\/emboj.2009.203","volume":"28","author":"L Izquierdo","year":"2009","unstructured":"Izquierdo, L. et al. Distinct donor and acceptor specificities of Trypanosoma brucei oligosaccharyltransferases. EMBO J. 28, 2650\u20132661 (2009).","journal-title":"EMBO J."},{"key":"67055_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.686691","volume":"12","author":"F Falconi-Agapito","year":"2021","unstructured":"Falconi-Agapito, F. et al. Dynamics of the magnitude, breadth and depth of the antibody response at epitope level following dengue infection. Front. Immunol. 12, 686691 (2021).","journal-title":"Front. Immunol."},{"key":"67055_CR53","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.1247749","volume":"343","author":"DL Akey","year":"2014","unstructured":"Akey, D. L. et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 343, 881\u2013885 (2014).","journal-title":"Science"},{"key":"67055_CR54","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1099\/0022-1317-75-5-1183","volume":"75","author":"MJ Pryor","year":"1994","unstructured":"Pryor, M. J. & Wright, P. J. Glycosylation mutants of dengue virus NS1 protein. J. Gen. Virol. 75, 1183\u20131187 (1994).","journal-title":"J. Gen. Virol."},{"key":"67055_CR55","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3389\/fimmu.2019.01568","volume":"10","author":"A Grifoni","year":"2019","unstructured":"Grifoni, A. et al. Characterization of magnitude and antigen specificity of HLA-DP, DQ, and DRB3\/4\/5 restricted DENV-specific CD4+ T cell responses. Front. Immunol. 10, 1568 (2019).","journal-title":"Front. Immunol."},{"key":"67055_CR56","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41586-024-07783-5","volume":"633","author":"EH Augestad","year":"2024","unstructured":"Augestad, E. H. et al. The hepatitis C virus envelope protein complex is a dimer of heterodimers. Nature 633, 704\u2013709 (2024).","journal-title":"Nature"},{"key":"67055_CR57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.abn9884","volume":"378","author":"A Torrents de la Pena","year":"2022","unstructured":"Torrents de la Pena, A. et al. Structure of the hepatitis C virus E1E2 glycoprotein complex. Science 378, 263\u2013269 (2022).","journal-title":"Science"},{"key":"67055_CR58","doi-asserted-by":"publisher","first-page":"10117","DOI":"10.1074\/jbc.M115.643528","volume":"290","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. Structural basis for penetration of the glycan shield of hepatitis C virus E2 glycoprotein by a broadly neutralizing human antibody. J. Biol. Chem. 290, 10117\u201310125 (2015).","journal-title":"J. Biol. Chem."},{"key":"67055_CR59","doi-asserted-by":"publisher","first-page":"12473","DOI":"10.1128\/JVI.01138-09","volume":"83","author":"TJ Broering","year":"2009","unstructured":"Broering, T. J. et al. Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus. J. Virol. 83, 12473\u201312482 (2009).","journal-title":"J. Virol."},{"key":"67055_CR60","doi-asserted-by":"crossref","unstructured":"Czarnota, A. et al. Effect of glycan shift on antibodies against hepatitis C virus E2 412\u2013425 epitope elicited by chimeric sHBsAg-based virus-like particles. Microbiol. Spectr. 11, e0254622 (2023).","DOI":"10.1128\/spectrum.02546-22"},{"key":"67055_CR61","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nsmb.2594","volume":"20","author":"L Kong","year":"2013","unstructured":"Kong, L. et al. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat. Struct. Mol. Biol. 20, 796\u2013803 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"67055_CR62","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1021\/acschembio.7b00319","volume":"12","author":"J Orwenyo","year":"2017","unstructured":"Orwenyo, J. et al. Systematic synthesis and binding study of HIV V3 glycopeptides reveal the fine epitopes of several broadly neutralizing antibodies. ACS Chem. Biol. 12, 1566\u20131575 (2017).","journal-title":"ACS Chem. Biol."},{"key":"67055_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4571-5","volume":"19","author":"RM Dawood","year":"2019","unstructured":"Dawood, R. M. et al. A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice. BMC Infect. Dis. 19, 932 (2019).","journal-title":"BMC Infect. Dis."},{"key":"67055_CR64","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41589-023-01539-4","volume":"20","author":"E Makrydaki","year":"2024","unstructured":"Makrydaki, E. et al. Immobilized enzyme cascade for targeted glycosylation. Nat. Chem. Biol. 20, 732\u2013741 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"67055_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34029-7","volume":"13","author":"T Jaroentomeechai","year":"2022","unstructured":"Jaroentomeechai, T. et al. A universal glycoenzyme biosynthesis pipeline that enables efficient cell-free remodeling of glycans. Nat. Commun. 13, 6325 (2022).","journal-title":"Nat. Commun."},{"key":"67055_CR66","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1021\/cb200429n","volume":"7","author":"LX Wang","year":"2012","unstructured":"Wang, L. X. & Lomino, J. V. Emerging technologies for making glycan-defined glycoproteins. ACS Chem. Biol. 7, 110\u2013122 (2012).","journal-title":"ACS Chem. Biol."},{"key":"67055_CR67","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1038\/s41596-022-00799-z","volume":"18","author":"JC Stark","year":"2023","unstructured":"Stark, J. C. et al. Rapid biosynthesis of glycoprotein therapeutics and vaccines from freeze-dried bacterial cell lysates. Nat. Protoc. 18, 2374\u20132398 (2023).","journal-title":"Nat. Protoc."},{"key":"67055_CR68","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","volume":"41","author":"FW Studier","year":"2005","unstructured":"Studier, F. W. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41, 207\u2013234 (2005).","journal-title":"Protein Expr. Purif."},{"key":"67055_CR69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jbbm.2005.12.008","volume":"67","author":"F Van Den Ent","year":"2006","unstructured":"Van Den Ent, F. & L\u00f6we, J. RF cloning: a restriction-free method for inserting target genes into plasmids. J. Biochem. Biophys. Methods 67, 67\u201374 (2006).","journal-title":"J. Biochem. Biophys. Methods"},{"key":"67055_CR70","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1126\/science.aar5140","volume":"359","author":"R Wild","year":"2018","unstructured":"Wild, R. et al. Structure of the yeast oligosaccharyltransferase complex gives insight into eukaryotic N-glycosylation. Science 359, 545\u2013550 (2018).","journal-title":"Science"},{"key":"67055_CR71","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nchembio.2539","volume":"14","author":"KW Moremen","year":"2018","unstructured":"Moremen, K. W. et al. Expression system for structural and functional studies of human glycosylation enzymes. Nat. Chem. Biol. 14, 156 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"67055_CR72","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/nprot.2006.4","volume":"1","author":"H Schagger","year":"2006","unstructured":"Schagger, H. Tricine-SDS-PAGE. Nat. Protoc. 1, 16\u201322 (2006).","journal-title":"Nat. Protoc."},{"key":"67055_CR73","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"67055_CR74","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2011","unstructured":"Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"67055_CR75","doi-asserted-by":"publisher","first-page":"W320","DOI":"10.1093\/nar\/gku316","volume":"42","author":"X Robert","year":"2014","unstructured":"Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320\u2013W324 (2014).","journal-title":"Nucleic Acids Res."},{"key":"67055_CR76","doi-asserted-by":"crossref","unstructured":"Schneider, C., Rasband, W. & Eliceiri, K. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","DOI":"10.1038\/nmeth.2089"},{"key":"67055_CR77","doi-asserted-by":"publisher","first-page":"D1523","DOI":"10.1093\/nar\/gkaa1012","volume":"49","author":"Y Watanabe","year":"2021","unstructured":"Watanabe, Y., Aoki-Kinoshita, K. F., Ishihama, Y. & Okuda, S. GlycoPOST realizes FAIR principles for glycomics mass spectrometry data. Nucleic Acids Res. 49, D1523\u2013D1528 (2021).","journal-title":"Nucleic Acids Res."},{"key":"67055_CR78","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 53, D543\u2013D553 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67055-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67055-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67055-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:27:35Z","timestamp":1768472855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67055-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67055"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67055-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have filed a patent application on the use of an enzymatic pipeline that employs some of the enzymes reported in the text (EP460037A1).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"369"}}